-
FDA Mandates “iPLEDGE” Accutane Registry in Effort to Prevent Birth Defects
Patients Must Register by December 31, 2005 to Get Accutane Re-fills In mid-August 2005 the FDA mandated that all patients who uses the acne drug Accutane will have to enroll in a national Accutane…
-
Serzone MDL Class Action Settlement Approved by Federal Court Judge Godwin
More Than 2500 Potential Claimants, However, "Opt-out" of This Serzone Settlement United States District Court Judge Joseph R. Godwin, on September 2, 2005, gave final court approval to a $70 million settlement of Serzone…
-
Eli Lilly Sues Its Insurers to Partially Fund $1 Billion Zyprexa Settlement
$500 Million Sought From Five Insurance Companies for Payment of Zyprexa Claims In a September 2, 2005 article by Jeff Swiatek, of The Indianapolis Star, it was reported that Eli Lilly and Co. filed…
-
Anti-Cancer Drug Herceptin Associated With Significant Risk of Cardiotoxicity
Genentech Says Its Breast Cancer Drug Can Increase Risk of Heart Problems The FDA and Genentech, Inc. have warned healthcare professionals by means of an August 2005 "Dear Doctor" letter of study data linking…
-
Analyst Report Forecasts Some Choppy Waters for Return of Tysabri
FDA Adverse Event Reports Show Tysabri May Be Tied To Other Serious Side Effects On August 29, 2005 The Wall Street Journal ("WSJ") reported that a list of adverse event reports made to the…
-
Adderall: Health Canada Allows Shire’s ADHD Drug Back on Market
Sudden Cardiac Death and Stroke Case Reports Had Caused Health Canada to Recall Adderall in February 2005 Health Canada announced on August 24, 2005 that Adderall XR, an attention deficit hyperactivity disorder ("ADHD") drug,…
